Yolanda Piña Selected Research

beta Subunit Luteinizing Hormone

2/2012	Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LH(BETA)T(AG) retinal tumors.
1/2012	Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LH(BETA)T(AG) retinal tumors.
1/2011	Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LH(BETA)T(AG) retinoblastoma tumors.
12/2010	Focal, periocular delivery of 2-deoxy-D-glucose as adjuvant to chemotherapy for treatment of advanced retinoblastoma.
10/2010	Antiangiogenic activity of 2-deoxy-D-glucose.
6/2010	Gelatinase expression in retinoblastoma: modulation of LH(BETA)T(AG) retinal tumor development by anecortave acetate.
5/2010	Impact of tumor-associated macrophages in LH(BETA)T(AG) mice on retinal tumor progression: relation to macrophage subtype.
12/2009	Increased hypoxia following vessel targeting in a murine model of retinoblastoma.
3/2009	Blood vessel maturation in retinoblastoma tumors: spatial distribution of neovessels and mature vessels and its impact on ocular treatment.
7/2008	Targeting hypoxia, a novel treatment for advanced retinoblastoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yolanda Piña Research Topics

Disease

18	Neoplasms (Cancer) 01/2021 - 06/2007
15	Retinoblastoma (Glioblastoma, Retinal) 02/2012 - 06/2007
10	Retinal Neoplasms 02/2012 - 06/2007
4	Brain Neoplasms (Brain Tumor) 04/2022 - 03/2020
3	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2009
3	Hypoxia (Hypoxemia) 02/2012 - 12/2009
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2021
2	Glioma (Gliomas) 01/2021 - 03/2020
1	Circulating Neoplastic Cells 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Leukoencephalopathies 01/2021
1	Astrocytoma (Pilocytic Astrocytoma) 03/2020
1	Sclerosis 09/2010
1	Endophthalmitis (Ophthalmia) 05/2010
1	Necrosis 12/2007
1	Vascular Tissue Neoplasms 06/2007

Drug/Important Bio-Agent (IBA)

12	beta Subunit Luteinizing HormoneIBA 02/2012 - 06/2007
6	Carboplatin (JM8)FDA LinkGeneric 12/2010 - 12/2007
4	Deoxyglucose (2 Deoxy D glucose)IBA 01/2012 - 07/2008
3	anecortave acetateIBA 01/2011 - 12/2009
3	pimonidazoleIBA 12/2010 - 07/2008
2	Immune Checkpoint InhibitorsIBA 04/2022 - 01/2021
2	dabrafenibIBA 01/2021 - 03/2020
2	trametinibIBA 01/2021 - 03/2020
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 03/2020
2	Hematoxylin (Haematoxylon)IBA 02/2012 - 01/2009
2	Eosine Yellowish-(YS) (Eosin)IBA 02/2012 - 01/2009
2	Angiogenesis InhibitorsIBA 06/2010 - 12/2009
1	Cell-Free Nucleic AcidsIBA 01/2022
1	IpilimumabIBA 01/2021
1	NivolumabIBA 01/2021
1	Anabolic Androgenic SteroidsIBA 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	BenzodiazepinesIBA 01/2021
1	InsecticidesIBA 01/2021
1	Mitogen-Activated Protein KinasesIBA 01/2021
1	matrigelIBA 10/2010
1	Melphalan (Alkeran)FDA LinkGeneric 09/2010
1	GelatinasesIBA 06/2010
1	Matrix Metalloproteinases (MMPs)IBA 06/2010
1	Bevacizumab (Avastin)FDA Link 05/2010
1	Green Fluorescent ProteinsIBA 05/2010
1	Periodic AcidIBA 01/2009
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 12/2008
1	Protein Isoforms (Isoforms)IBA 12/2008
1	Caspase 3 (Caspase-3)IBA 12/2007

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 01/2022 - 12/2007
8	Therapeutics 01/2021 - 06/2007
6	Injections 01/2012 - 12/2009
3	Aftercare (After-Treatment) 12/2010 - 12/2007
1	Precision Medicine 03/2020
1	Complementary Therapies (Alternative Medicine) 01/2011
1	Lasers (Laser) 09/2010
1	Laser Therapy (Surgery, Laser) 09/2010
1	Intravitreal Injections 05/2010
1	Intraperitoneal Injections 12/2009
1	Intraocular Injections 12/2009